Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Tandem Diabetes Care (TNDM) Return on Equity (2016 - 2025)

Historic Return on Equity for Tandem Diabetes Care (TNDM) over the last 12 years, with Q3 2025 value amounting to 1.53%.

  • Tandem Diabetes Care's Return on Equity fell 9900.0% to 1.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.53%, marking a year-over-year decrease of 9900.0%. This contributed to the annual value of 0.33% for FY2024, which is 2600.0% up from last year.
  • Per Tandem Diabetes Care's latest filing, its Return on Equity stood at 1.53% for Q3 2025, which was down 9900.0% from 1.42% recorded in Q2 2025.
  • Tandem Diabetes Care's Return on Equity's 5-year high stood at 0.06% during Q3 2021, with a 5-year trough of 1.53% in Q3 2025.
  • Over the past 5 years, Tandem Diabetes Care's median Return on Equity value was 0.51% (recorded in 2024), while the average stood at 0.46%.
  • In the last 5 years, Tandem Diabetes Care's Return on Equity soared by 3300bps in 2024 and then plummeted by -9900bps in 2025.
  • Over the past 5 years, Tandem Diabetes Care's Return on Equity (Quarter) stood at 0.04% in 2021, then tumbled by -686bps to 0.22% in 2022, then tumbled by -223bps to 0.71% in 2023, then surged by 46bps to 0.38% in 2024, then plummeted by -298bps to 1.53% in 2025.
  • Its Return on Equity was 1.53% in Q3 2025, compared to 1.42% in Q2 2025 and 0.88% in Q1 2025.